Published in Br J Cancer on September 24, 2013
Selective inhibition of regulatory T cells by targeting the PI3K-Akt pathway. Cancer Immunol Res (2014) 0.91
Immune response after photodynamic therapy increases anti-cancer and anti-bacterial effects. World J Immunol (2014) 0.87
Boosting Tumor-Specific Immunity Using PDT. Cancers (Basel) (2016) 0.84
Photodynamic Therapy of Non-Small Cell Lung Cancer. Narrative Review and Future Directions. Ann Am Thorac Soc (2016) 0.83
Enhancing the efficacy of cytotoxic agents for cancer therapy using photochemical internalisation. Int J Cancer (2015) 0.81
Anti-tumor immunity of BAM-SiPc-mediated vascular photodynamic therapy in a BALB/c mouse model. Cell Mol Immunol (2015) 0.78
T-cell mediated anti-tumor immunity after photodynamic therapy: why does it not always work and how can we improve it? Photochem Photobiol Sci (2015) 0.77
Immunoregulatory Cell Depletion Improves the Efficacy of Photodynamic Therapy-Generated Cancer Vaccines. Int J Mol Sci (2015) 0.77
Immunological aspects of antitumor photodynamic therapy outcome. Cent Eur J Immunol (2016) 0.76
Targeting Antitumor Immune Response for Enhancing the Efficacy of Photodynamic Therapy of Cancer: Recent Advances and Future Perspectives. Oxid Med Cell Longev (2016) 0.75
Activated T cells exhibit increased uptake of silicon phthalocyanine Pc 4 and increased susceptibility to Pc 4-photodynamic therapy-mediated cell death. Photochem Photobiol Sci (2016) 0.75
Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions. Cancers (Basel) (2017) 0.75
Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med (2010) 67.34
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med (2004) 22.96
Regulatory T cells and immune tolerance. Cell (2008) 18.77
Photodynamic therapy. J Natl Cancer Inst (1998) 12.83
Regulation of immune responses by TGF-beta. Annu Rev Immunol (1998) 8.01
Photodynamic therapy for cancer. Nat Rev Cancer (2003) 8.00
Induction of tumor immunity by removing CD25+CD4+ T cells: a common basis between tumor immunity and autoimmunity. J Immunol (1999) 7.60
Photodynamic therapy of cancer: an update. CA Cancer J Clin (2011) 6.08
Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res (2001) 5.48
Inhibition of CD4(+)25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide. Blood (2004) 5.02
CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative. Eur J Immunol (2004) 5.02
How does photodynamic therapy work? Photochem Photobiol (1992) 4.49
Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer (2006) 3.93
Role of transforming growth factor Beta in human cancer. J Clin Oncol (2005) 3.53
Recruitment of latent pools of high-avidity CD8(+) T cells to the antitumor immune response. J Exp Med (2005) 3.22
An update on photodynamic therapy applications. J Clin Laser Med Surg (2002) 2.94
A review of progress in clinical photodynamic therapy. Technol Cancer Res Treat (2005) 2.44
Photodynamic therapy in oncology: mechanisms and clinical use. J Natl Cancer Inst (1993) 2.24
The immunodominant major histocompatibility complex class I-restricted antigen of a murine colon tumor derives from an endogenous retroviral gene product. Proc Natl Acad Sci U S A (1996) 2.24
Tumor-induced expansion of regulatory T cells by conversion of CD4+CD25- lymphocytes is thymus and proliferation independent. Cancer Res (2006) 1.97
Depletion of CD25+ regulatory cells uncovers immune responses to shared murine tumor rejection antigens. Eur J Immunol (2002) 1.88
Targeting the transforming growth factor-beta signaling pathway in human cancer. Expert Opin Investig Drugs (2010) 1.57
TGF-beta and regulatory T cell in immunity and autoimmunity. J Clin Immunol (2008) 1.49
Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response. Cancer Res (2005) 1.49
Depletion of CD4+ CD25+ regulatory cells augments the generation of specific immune T cells in tumor-draining lymph nodes. J Immunother (2002) 1.47
Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigen. J Immunol (1996) 1.43
Macrophage production of TGF-beta and regulation by TGF-beta. Ann N Y Acad Sci (1990) 1.33
Induction of tumor immunity by photodynamic therapy. J Clin Laser Med Surg (1996) 1.31
Cyclophosphamide-induced immunologically mediated regression of a cyclophosphamide-resistant murine tumor: a consequence of eliminating precursor L3T4+ suppressor T-cells. Cancer Res (1989) 1.31
Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy. Br J Cancer (1995) 1.29
Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model. Proc Natl Acad Sci U S A (2008) 1.23
Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcome. Cancer Immunol Immunother (2011) 1.21
DAMPs and PDT-mediated photo-oxidative stress: exploring the unknown. Photochem Photobiol Sci (2011) 1.20
Photodynamic therapy and anti-tumor immunity. Lasers Surg Med (2006) 1.17
Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumors. Cancer Lett (2002) 1.15
Attenuated inflammatory response in aged mice brains following stroke. PLoS One (2011) 1.14
Photodynamic therapy of tumors can lead to development of systemic antigen-specific immune response. PLoS One (2010) 1.12
Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine. Cancer Immunol Immunother (2012) 1.10
Effective photoimmunotherapy of murine colon carcinoma induced by the combination of photodynamic therapy and dendritic cells. Clin Cancer Res (2004) 1.09
Immunostimulatory effects of low-dose cyclophosphamide are controlled by inducible nitric oxide synthase. Cancer Res (2005) 1.04
B lymphocytes inhibit human osteoclastogenesis by secretion of TGFbeta. J Cell Biochem (2000) 0.98
Acute phase response-associated systemic neutrophil mobilization in mice bearing tumors treated by photodynamic therapy. Int Immunopharmacol (2006) 0.94
Age-dependent tolerance to an endogenous tumor-associated antigen. Vaccine (2008) 0.92
Acute phase response induction by cancer treatment with photodynamic therapy. Int J Cancer (2008) 0.92
The immunosuppressive side of PDT. Photochem Photobiol Sci (2011) 0.86
Minichromosome maintenance 2 bound with retroviral Gp70 is localized to cytoplasm and enhances DNA-damage-induced apoptosis. PLoS One (2012) 0.86
The nature and significance of platelet products in human plasma. Br J Haematol (1967) 2.84
Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Xeroderma Pigmentosum Study Group. Lancet (2001) 2.79
Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis. Br J Dermatol (2013) 2.70
Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway. Cell (1996) 2.32
Srg3, a mouse homolog of yeast SWI3, is essential for early embryogenesis and involved in brain development. Mol Cell Biol (2001) 2.26
Coding and noncoding variation of the human calcium-channel beta4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia. Am J Hum Genet (2000) 2.21
Frequency and therapeutic implications of "skip metastases" in the neck from squamous carcinoma of the oral tongue. Head Neck (1997) 2.16
Efficacy of psoralen plus ultraviolet A therapy vs. biologics in moderate to severe chronic plaque psoriasis: retrospective data analysis of a patient registry. Br J Dermatol (2011) 2.07
Apolipoprotein E and cognitive change in an elderly population. Ann Neurol (1996) 2.05
Photodynamic therapy targeted to pathogens. Int J Immunopathol Pharmacol (2004) 1.93
Targeted antimicrobial photochemotherapy. Antimicrob Agents Chemother (1998) 1.79
Evaluation of the antioxidant potential of natural products. Comb Chem High Throughput Screen (1998) 1.79
Molecular characterization of folate receptor 1 mutations delineates cerebral folate transport deficiency. Brain (2012) 1.77
Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo. Br J Dermatol (2011) 1.75
Placental vascular pathology findings and pathways to preterm delivery. Am J Epidemiol (2009) 1.73
Combination photoimmunotherapy and cisplatin: effects on human ovarian cancer ex vivo. J Natl Cancer Inst (1999) 1.71
Language lateralization by Wada test and fMRI in 100 patients with epilepsy. Neurology (2003) 1.70
Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma. Blood (2000) 1.69
Morphology, growth, chromosomal pattern and fibrinolytic activity of two new human neuroblastoma cell lines. Cancer Res (1977) 1.66
Evaluation of posttreatment response of hepatocellular carcinoma with contrast-enhanced coded phase-inversion harmonic US: comparison with dynamic CT. Radiology (2001) 1.52
Randomized double-blinded placebo-controlled intra-individual trial on topical treatment with a 1,25-dihydroxyvitamin D₃ analogue in polymorphic light eruption. Br J Dermatol (2011) 1.50
Immunologic protection afforded by sunscreens beyond designated sun protection factors? J Invest Dermatol (1998) 1.48
Photopheresis for renal allograft rejection. Lancet (1995) 1.47
Slow degradation of aggregates of the Alzheimer's disease amyloid beta-protein by microglial cells. J Biol Chem (1997) 1.45
A critical reappraisal of Waddell's technique for ultraviolet spectrophotometric protein estimation. Anal Biochem (1983) 1.43
The clinical and ocular manifestations of Takayasu arteritis. Retina (2001) 1.42
Electrophysiologic effects of the new class III antiarrhythmic drug dofetilide compared to the class IA antiarrhythmic drug quinidine in experimental canine atrial flutter: role of dispersion of refractoriness in antiarrhythmic efficacy. J Cardiovasc Electrophysiol (1996) 1.42
Minor salivary gland tumors of the palate: clinical and pathologic correlates of outcome. Laryngoscope (1995) 1.42
Predictors of long-term survival after liver transplantation for metastatic endocrine tumors: an 85-case French multicentric report. Am J Transplant (2008) 1.38
Acute encephalopathy with vigabatrin. Lancet (1993) 1.38
Photodynamic therapy of superficial basal cell carcinoma by instillation of aminolevulinic acid and irradiation with visible light. Arch Dermatol (1997) 1.38
Invasive in vivo measurement of rear-, mid- and forefoot motion during walking. Gait Posture (2007) 1.37
Foot kinematics during walking measured using bone and surface mounted markers. J Biomech (2007) 1.28
Graded balloon dilation atrial septostomy as a bridge to lung transplantation in pulmonary hypertension. Am Heart J (1993) 1.27
Physical shock wave mediates membrane hyperpolarization and Ras activation for osteogenesis in human bone marrow stromal cells. Biochem Biophys Res Commun (2001) 1.26
Hypertonic saline resuscitation decreases susceptibility to sepsis after hemorrhagic shock. J Trauma (1997) 1.26
Rhabdomyosarcoma of the nose and paranasal sinuses in adults and children. Otolaryngol Head Neck Surg (1995) 1.24
Dose-dependent protective effect of coffee, tea, and smoking in Parkinson's disease: a study in ethnic Chinese. J Neurol Sci (2003) 1.23
Matrix metalloproteinase expression in nonrheumatic aortic stenosis. Cardiovasc Pathol (2000) 1.21
Experimental photoimmunotherapy of hepatic metastases of colorectal cancer with a 17.1A chlorin(e6) immunoconjugate. Cancer Res (2000) 1.20
Cytoplasmic molecular delivery with shock waves: importance of impulse. Biophys J (2000) 1.20
Targeted therapies for prostate cancer against the prostate specific membrane antigen. Curr Drug Targets (2009) 1.19
The action of baclofen on neurons of the substantia nigra and of the ventral tegmental area. Brain Res (1977) 1.19
Prognostic variables in parotid gland cancer. Arch Otolaryngol Head Neck Surg (1991) 1.19
Epidermal growth factor receptor-targeted immunophotodiagnosis and photoimmunotherapy of oral precancer in vivo. Cancer Res (2001) 1.18
The biological activity of d- and l-baclofen (Lioresal). Eur J Pharmacol (1978) 1.17
Spontaneous sharp waves in human neocortical slices excised from epileptic patients. Brain (1998) 1.17
Topical antimicrobials for burn wound infections. Recent Pat Antiinfect Drug Discov (2010) 1.17
An evaluation of the associations of leukemia and rubber industry solvent exposures. Am J Ind Med (1984) 1.16
Epidemiological, clinical, and neuropathological study of apolipoprotein E genotype in Alzheimer's disease. Ann N Y Acad Sci (1996) 1.13
Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells. Int J Oncol (1999) 1.12
Serratia marcescens endophthalmitis associated with intravitreal injections of bevacizumab. Eye (Lond) (2009) 1.11
Photodynamic therapy of orthotopic prostate cancer with benzoporphyrin derivative: local control and distant metastasis. Cancer Res (1998) 1.11
Central actions of histamine: microelectrophoretic studies. Brain Res (1977) 1.10
Evaluation of atpB nucleotide sequences for phylogenetic studies of ferns and other pteridophytes. Am J Bot (1997) 1.10
The measurement of fibrinogen and its derivatives. I. Examination of methods of measurement of clottable fibrinogen. Med Lab Technol (1971) 1.09
Microscopic cut-through of cancer in the surgical treatment of squamous carcinoma of the tongue. Prognostic and therapeutic implications. Am J Surg (1986) 1.09
Targeted photodestruction of human colon cancer cells using charged 17.1A chlorin e6 immunoconjugates. Br J Cancer (2000) 1.08
Relation of photosensitivity to epileptic syndromes. J Neurol Neurosurg Psychiatry (1986) 1.07
Intraperitoneal photodynamic therapy of human epithelial ovarian carcinomatosis in a xenograft murine model. Cancer Res (1996) 1.06
The effect of charge on cellular uptake and phototoxicity of polylysine chlorin(e6) conjugates. Photochem Photobiol (1997) 1.06
Effects of incorporation of immunoglobulin G and complement component C1q on uptake and degradation of Alzheimer's disease amyloid fibrils by microglia. J Biol Chem (2000) 1.05
EphA2 is a critical oncogene in melanoma. Oncogene (2011) 1.05
Exposure of workers to airborne microorganisms in open-air swine houses. Appl Environ Microbiol (2001) 1.04
Extraction of retinol and cholesterol by intraocular silicone oils. Ophthalmology (1988) 1.03
Depression and the vision-related quality of life in patients with retinitis pigmentosa. Br J Ophthalmol (2008) 1.02
Identification of human asparaginyl endopeptidase (legumain) as an inhibitor of osteoclast formation and bone resorption. J Biol Chem (1999) 1.02
A suprachoroidal electrical retinal stimulator design for long-term animal experiments and in vivo assessment of its feasibility and biocompatibility in rabbits. J Biomed Biotechnol (2008) 1.02
Immunoephelometric determination of fibrinogen and its derivatives in plasma. J Immunol Methods (1972) 1.02
Structure-activity relationships of putative primaquine metabolites causing methemoglobin formation in canine hemolysates. Toxicol Appl Pharmacol (1985) 1.02
Computed tomography-based tissue-engineered scaffolds in craniomaxillofacial surgery. Int J Med Robot (2007) 1.02
Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. Br J Dermatol (2003) 1.02
Non-pulmonary Rhodococcus equi infections in patients with acquired immune deficiency syndrome (AIDS). J Clin Pathol (1987) 1.01
Commission on European Affairs: appropriate standards of epilepsy care across Europe.ILEA. Epilepsia (1997) 1.01
Cortical self-regulation in patients with epilepsies. Epilepsy Res (1993) 1.01
Pharmacokinetic interactions of the new antiepileptic drugs. Clin Pharmacokinet (1996) 0.99
Lamotrigine clinical pharmacokinetics. Clin Pharmacokinet (1993) 0.99
Effects of corticosteroids on HCV infection. Int J Immunopharmacol (1999) 0.99
Biodistribution of charged F(ab')2 photoimmunoconjugates in a xenograft model of ovarian cancer. Br J Cancer (1997) 0.99
Immortalization of osteoclast precursors by targeting Bcl -XL and Simian virus 40 large T antigen to the osteoclast lineage in transgenic mice. J Clin Invest (1998) 0.99
Surgical repair after bile duct and vascular injuries during laparoscopic cholecystectomy: when and how? World J Surg (2001) 0.99
Narrowband (311-nm) UV-B therapy for small plaque parapsoriasis and early-stage mycosis fungoides. Arch Dermatol (1999) 0.98
Proceedings: A high titre circulating inhibitor of human factor V: clinical, biochemical and immunological features and its treatment by plasmapheresis. Thromb Diath Haemorrh (1975) 0.98
Notch1 confers a resistance to glucocorticoid-induced apoptosis on developing thymocytes by down-regulating SRG3 expression. Proc Natl Acad Sci U S A (2001) 0.98
Mechanism of the effect of acute ethanol on hexobarbital metabolism. Biochem Pharmacol (1976) 0.98
Reduction of bacterial translocation and intestinal structural alterations by heparin in a murine burn injury model. J Trauma (1994) 0.98
A green fluorescent protein-expressing murine tumour but not its wild-type counterpart is cured by photodynamic therapy. Br J Cancer (2006) 0.97
Extensive post-traumatic ossification of the patellar tendon. A report of two cases. J Bone Joint Surg Br (1999) 0.97
[The influence of pulse current on electroforming (2nd. report)]. Kanagawa Shigaku (1986) 0.97
Factors contributing to retinal detachment after transscleral fixation of posterior chamber intraocular lenses. J Cataract Refract Surg (1998) 0.97
[Surgical strategy in the treatment of synchronous hepatic metastases of colorectal cancers. Analysis of a series of 59 operated on patients]. Chirurgie (1999) 0.96
Photodetector sensitivity level and heidelberg retina flowmeter measurements in humans. Invest Ophthalmol Vis Sci (2001) 0.96
Expression of the very low-density lipoprotein receptor (VLDL-r), an apolipoprotein-E receptor, in the central nervous system and in Alzheimer's disease. J Neuropathol Exp Neurol (1996) 0.95
Influence of biopsy on the prognosis of cutaneous melanoma of the head and neck. Head Neck (1996) 0.95
[Paroxysmal dysarthria and ataxia. A pathognomonic seizure syndrome in multiple sclerosis (author's transl)]. J Neurol (1974) 0.95
Hypertension and cardiac impairments increase stroke risk. Geriatrics (1978) 0.95
Purification and properties of a diacetyl reductase from Escherichia coli. J Bacteriol (1974) 0.95
T1796A BRAF mutation is absent in Merkel cell carcinoma. Br J Dermatol (2005) 0.95
The significance of variations in immunoreactive and clottable fibrinogen in health and following thrombosis. J Clin Pathol (1972) 0.94
In vivo evidence of enhanced guanylyl cyclase activation during the hyperdynamic circulation of acute liver failure. Hepatology (1994) 0.94